Increasing the activity of monoclonal antibody therapeutics by continuous chromatography (MCSGP)

Biotechnology and Bioengineering

Volumn 107, Issue 4, 2010, Pages 652-662

  Muller Spath T ^a,b   Krattli M ^a   Aumann, L ^a,b   Strohlein G ^a,b   Morbidelli, M ^a  

^a ETH ZURICH   (Switzerland)

^b CHROMACON AG   (Switzerland)

Author keywords

Biological activity; Continuous chromatography; MCSGP; Monoclonal antibody

Indexed keywords

ANTIBODY THERAPEUTICS; AVASTIN; BATCH CHROMATOGRAPHY; BIOLOGICAL ACTIVITIES; CHARGED PROTEINS; CONTINUOUS CHROMATOGRAPHY; COUNTER CURRENT; ERBITUX; FEED COMPOSITIONS; GRADIENT CHROMATOGRAPHY; HERCEPTIN; MCSGP; MODEL SIMULATION; MONOCLONAL ANTIBODIES (MAB); PERFORMANCE INDICATORS; PRODUCT STREAMS; STATIONARY PHASIS;

BENCHMARKING; BIOACTIVITY; COMPUTER SIMULATION; ION EXCHANGE; MONOCLONAL ANTIBODIES; SURFACE PLASMON RESONANCE;

CHROMATOGRAPHY;

BEVACIZUMAB; CETUXIMAB; TRASTUZUMAB;

ARTICLE; BIOLOGICAL ACTIVITY; COMPARATIVE STUDY; DRUG ACTIVITY; DRUG PURIFICATION; DRUG PURITY; ELECTRIC CAPACITANCE; HUMAN; HUMAN CELL; ION EXCHANGE CHROMATOGRAPHY;

ANTIBODIES, MONOCLONAL; BIOTECHNOLOGY; CHROMATOGRAPHY, ION EXCHANGE; IMMUNOLOGIC FACTORS;

EID: 78149341322     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.22843     Document Type: Article

References (24)

1. Aumann L, Morbidelli M. 2007. A continuous multicolumn countercurrent solvent gradient purification (MCSGP) process. Biotechnol Bioeng 98(5): 1043-1055.
2. Aumann L, Morbidelli M. 2008. A semicontinuous 3-column Countercurrent Solvent Gradient Purification (MCSGP) process. Biotechnol Bioeng 99(3): 728-733.
3. Aumann L, Stroehlein G, Morbidelli M. 2007. Parametric study of a 6-column countercurrent solvent gradient purification (MCSGP) unit. Biotechnol Bioeng 98(5): 1029-1042.
4. Glynn J, Boyle D, Wealand J, Miller-Cary E, Chen B, Mensah P. 2010. Advances in monoclonal antibody purification. Biopharm Int 4-+.
5. Grossmann C, Ströhlein G, Morari M, Morbidelli M. 2010. Optimizing model predictive control of the chromatographic multi-column solvent gradient purification (MCSGP) process. J Process Control 20(5): 618-629.
6. Guiochon G. 1994. Fundamentals of preparative and nonlinear chromatography. Boston: Academic Press.
7. Harris RJ, Kabakoff B, Macchi FD, Shen FJ, Kwong M, Andya JD, Shire SJ, Bjork N, Totpal K, Chen AB. 2001. Identification of multiple sources of charge heterogeneity in a recombinant antibody. J Chromatogr B 752(2): 233-245.
8. Jefferis R. 2009. Glycosylation as a strategy to improve antibody-based therapeutics. Nature Rev Drug Discov 8(3): 226-234.
9. Kunkel JP, Jan DCH, Butler M, Jamieson JC. 2000. Comparisons of the glycosylation of a monoclonal antibody produced under nominally identical cell culture conditions in two different bioreactors. Biotechnol Prog 16(3): 462-470.
10. Liu YD, van Enk RZ, Flynn GC. 2009. Human antibody Fc deamidation in vivo. Biologicals 37(5): 313-322.
11. Miyabe K, Guiochon G. 2000. Determination of the lumped mass transfer rate coefficient by frontal analysis. J Chromatogr A 890(2): 211-223.
12. Muller-Spath T, Aumann L, Melter L, Strohlein G, Morbidelli M. 2008. Chromatographic separation of three monoclonal antibody variants using multicolumn countercurrent solvent gradient purification (MCSGP). Biotechnol Bioeng 100(6): 1166-1177.
13. Muller-Spath T, Aumann L, Morbidelli M. 2009. Role of cleaning-in-place in the purification of mAb supernatants using continuous cation exchange chromatography. Sep Sci Technol 44(1): 1-26.
14. Muller-Spath T, Aumann L, Ströhlein G, Kornmann H, Valax P, Delegrange L, Charbaut E, Baer G, Lamproye A, Johnck M, Schulte M, Morbidelli M. 2010. Two step capture and purification of IgG2 using multicolumn countercurrent solvent gradient purification (MCSGP). Biotechnol Bioeng 10-249.R1.
15. Muthing J, Kemminer SE, Conradt HS, Sagi D, Nimtz M, Karst U, Peter-Katalinic J. 2003. Effects of buffering conditions and culture pH on production rates and glycosylation of clinical phase I anti-melanoma mouse IgG3 monoclonal antibody R24. Biotechnol Bioeng 83(3): 321-334.
16. Pluschkell S, Blocker L, Geldart R, Hawrylik S, Mensah P, Okediadi C, Pias S, Subashi A, Zhu M. 2005. Development and integration of a new animal-component-free process for the production of UK-279, 276. In: Godia F, Fussenegger M, editors. Animal cell technology meets genomics. Dordrecht, The Netherlands: Springer Netherlands. pp 465-470. ISBN:1402027915.
17. Qian J, Liu T, Yang L, Daus A, Crowley R, Zhou QW. 2007. Structural characterization of N-linked oligosaccharides on monoclonal antibody cetuximab by the combination of orthogonal matrix-assisted laser desorption/ionization hybrid quadrupole-quadrupole time-of-flight tandem mass spectrometry and sequential enzymatic digestion. Anal Biochem 364(1): 8-18.
18. Sethuraman N, Stadheim TA. 2006. Challenges in therapeutic glycoprotein production. Curr Opin Biotechnol 17(4): 341-346.
19. Sosic Z, Houde D, Blum A, Carlage T, Lyubarskaya Y. 2008. Application of imaging capillary IEF for characterization and quantitative analysis of recombinant protein charge heterogeneity. Electrophoresis 29(21): 4368-4376.
20. Strohlein G, Aumann L, Mazzotti M, Morbidelli M. 2006. A continuous, counter-current multi-column chromatographic process incorporating modifier gradients for ternary separations. J Chromatogr A 1126(1-2): 338-346.
21. Vlasak J, Bussat MC, Wang SY, Wagner-Rousset E, Schaefer M, Klinguer-Hamour C, Kirchmeier M, Corvaia N, Ionescu R, Beck A. 2009. Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody. Anal Biochem 392(2): 145-154.
22. Walsh G. 2005. Biopharmaceuticals: Recent approvals and likely directions. Trends Biotechnol 23(11): 553-558.
23. Weitzhandler M, Farnan D, Horvath J, Rohrer JS, Slingsby RW, Avdalovic N, Pohl C. 1998. Protein variant separations by cation-exchange chromatography on tentacle-type polymeric stationary phases. J Chromatogr A 828(1-2): 365-372.
24. Yan BX, Steen S, Hambly D, Valliere-Douglass J, Bos TV, Smallwood S, Yates Z, Arroll T, Han YH, Gadgil H, Latypov RF, Wallace A, Lim A, Kleemann GR, Wang WC, Balland A. 2009. Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chain. J Pharm Sci 98(10): 3509-3521.